1 All‐cause mortality |
5 |
5300 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.10 [0.64, 1.89] |
2 All‐cause mortality: comparator as usual care |
4 |
4601 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.11 [0.64, 1.91] |
3 All‐cause mortality: comparator provision of individual drugs |
1 |
699 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.06, 15.88] |
4 All‐cause mortality: 3+ drugs |
4 |
3839 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.00 [0.56, 1.78] |
5 All‐cause mortality: 2+ drugs |
1 |
1461 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.19 [0.43, 11.24] |
6 Fatal or non‐fatal ASCVD events |
6 |
4517 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.26 [0.95, 1.66] |
7 Fatal and non‐fatal ASCVD events: primary prevention trials |
2 |
686 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.04, 3.23] |
8 Fatal and non‐fatal ASCVD events: secondary prevention trials |
4 |
3831 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.29 [0.97, 1.72] |
9 Fatal and non‐fatal ASCVD events: comparator provision of individual drugs |
2 |
906 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.63 [0.66, 3.98] |
10 Fatal and non‐fatal ASCVD events: comparator as usual care |
4 |
3611 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.22 [0.91, 1.64] |
11 Fatal and non‐fatal ASCVD events: 3+ drugs |
5 |
4306 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.28 [0.96, 1.69] |
12 Fatal and non‐fatal ASCVD events: 2 drugs |
1 |
211 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.39 [0.02, 8.05] |